Literature DB >> 17476869

Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2.

Nicola Scopinaro1, Francesco Papadia, Giuseppe Marinari, Giovanni Camerini, Gianfranco Adami.   

Abstract

BACKGROUND: Bariatric operations are the most powerful means of curing type 2 diabetes mellitus (T2D) and the other major components of the metabolic syndrome. Despite the very frequent occurrence of metabolic disturbances in patients with BMI from 30 to 35, there is a general reluctance to operate on these patients, as their disease is considered less severe.
METHODS: 7 T2D obese patients with mean BMI < 35 underwent BPD between 1976 and 1996 at the Azienda Ospedaliera Universitaria San Martino of Genoa, Italy. Mean age was 49 years, mean body weight 91 kg, and mean waist circumference 115 (M) and 98 (F) cm. The mean follow-up was 13 (10-18) years. All 7 patients had abnormally high values of serum triglyceride, serum cholesterol, and arterial pressure.
RESULTS: In all patients, serum glucose was normalized at 1,2, and 3 years. In 5 patients, a slight increase of serum glucose above 125 mg/dl was observed at or around 5 years, the values being maintained at all subsequent times, with no one value higher than 160 mg ever being recorded. The other 2 patients showed full resolution of diabetes at all follow-up times. Both serum cholesterol and triglyceride values fell to normal 1 year after BPD, and remained within the normal range in all 7 patients during the entire follow-up observation. Arterial pressure normalized in 6 cases and was improved in 1 case. No patient had excessive weight loss at any postoperative time.
CONCLUSIONS: T2D patients with BMI < 35 have very severe metabolic disturbances. Surgical therapy for these patients is warranted, and it should be performed as soon as possible, before the rapid evolution of the pattern leads them to a point where even the most effective metabolic surgery operation could be insufficient to yield complete and permanent control of their diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 17476869     DOI: 10.1007/s11695-007-9045-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  18 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  International Federation for the Surgery of Obesity. Statement on patient selection for bariatric surgery.

Authors: 
Journal:  Obes Surg       Date:  1997-02       Impact factor: 4.129

3.  Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion.

Authors:  Gian Franco Adami; Roberto Carlo Parodi; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Roberta Corvisieri; Nicola Scopinaro
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

4.  Energy and nitrogen absorption after biliopancreatic diversion.

Authors:  N Scopinaro; G M Marinari; F Pretolesi; F Papadia; F Murelli; P Marini; G F Adami
Journal:  Obes Surg       Date:  2000-10       Impact factor: 4.129

Review 5.  Metabolic implications of obesity: before and after gastric bypass.

Authors:  Donald W Richardson; Aaron I Vinik
Journal:  Gastroenterol Clin North Am       Date:  2005-03       Impact factor: 3.806

6.  Duodenal switch without gastric resection: results and observations after 6 years.

Authors:  Maria Laura Cossu; Giuseppe Noya; Gian Carlo Tonolo; Stefano Profili; Giovanni B Meloni; Matteo Ruggiu; Patrizia Brizzi; Franca Cossu; Luca Pilo; Pier Luigi Tilocca
Journal:  Obes Surg       Date:  2004 Nov-Dec       Impact factor: 4.129

7.  Morbid obesity and gastric bypass surgery: biochemical profile.

Authors:  V Silvestre; M Ruano; Y Domínguez; R Castro; M C G García-Lescun; A Rodríguez; A Marco; G García-Blanch
Journal:  Obes Surg       Date:  2004-10       Impact factor: 4.129

8.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

Authors:  B Larsson; K Svärdsudd; L Welin; L Wilhelmsen; P Björntorp; G Tibblin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

9.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

Authors:  L Lapidus; C Bengtsson; B Larsson; K Pennert; E Rybo; L Sjöström
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

10.  Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.

Authors:  W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

View more
  31 in total

1.  An invitation to our medical colleagues: work with us.

Authors:  Henry Buchwald; Nicola Scopinaro
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

2.  Surgical treatment of nonseverely obese patients with type 2 diabetes mellitus: sleeve gastrectomy with ileal transposition (SGIT) is the same as the neuroendocrine brake (NEB) procedure or ileal interposition associated with sleeve gastrectomy (II-SG), but ileal interposition with diverted sleeve gastrectomy (II-DSG) is the same as duodenal switch.

Authors:  Michel Gagner
Journal:  Surg Endosc       Date:  2011-02       Impact factor: 4.584

Review 3.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

Review 4.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

5.  Bariatric surgery provides unparalleled metabolic benefits.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

6.  Surgery for diabetes at lower BMI: some caution.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2008-08-30       Impact factor: 4.129

7.  A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations.

Authors:  Nicola Scopinaro; Francesco Papadia; Giovanni Camerini; Giuseppe Marinari; Dario Civalleri; Adami Gian Franco
Journal:  Obes Surg       Date:  2008-05-08       Impact factor: 4.129

8.  Bariatrics, metabolic dysfunction and the surgeon.

Authors:  Anil Sharma
Journal:  Indian J Surg       Date:  2010-11-30       Impact factor: 0.656

9.  Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

Authors:  A L DePaula; A L V Macedo; N Rassi; S Vencio; C A Machado; B R Mota; L Q Silva; A Halpern; V Schraibman
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

10.  Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.

Authors:  John A Batsis; Abel Romero-Corral; Maria L Collazo-Clavell; Michael G Sarr; Virend K Somers; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2008-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.